Opportunity Information: Apply for RFA AG 18 029
The National Institutes of Health (NIH) funding opportunity titled "Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01 - Clinical Trial Not Allowed)" (Funding Opportunity Number: RFA-AG-18-029; CFDA: 93.866) supports research projects that explain why some people who are clearly at high risk for Alzheimers disease never go on to develop dementia. The central idea is to study "cognitive resilience" and to do it in a way that goes beyond any single discipline, bringing together teams that can integrate biology, data science, and clinical or population-based knowledge. The work is framed around building predictive molecular models of resilience, meaning applicants are expected to use large, complex datasets to identify biological signatures and mechanisms that help preserve cognition even when risk factors are present.
The scientific emphasis is on high-dimensional molecular data, such as multi-omics or similarly rich molecular profiling, collected from individuals who remain dementia-free despite elevated risk. Rather than focusing only on Alzheimers pathology, the opportunity encourages approaches that can capture the complex biology that might protect the brain, compensate for damage, or delay clinical symptoms. A key deliverable implied by the announcement is a model or set of models that can predict resilience from molecular patterns, ideally robust enough to inform future research directions, target identification, or biomarker development. Because it is an R01 mechanism, the expectation is a substantial, hypothesis-driven research plan with strong analytic rigor and a clear path to producing generalizable knowledge.
Clinical trials are not allowed under this announcement, so proposals should not be designed as interventional studies that prospectively assign human participants to treatments or behavioral conditions to measure outcomes. The intent is better aligned with observational human studies, analysis of existing cohorts, secondary analysis of previously collected biospecimens and datasets, computational modeling, systems biology, and other non-trial research designs that can still directly address resilience biology. Applicants would typically be expected to justify cohort selection, define what "high risk" means in their context (for example, genetic risk, biomarker risk, family history, or other validated indicators), and clearly define how they will operationalize and measure resilience.
Eligibility is broad and includes many types of U.S. organizations: state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other eligible entities. The announcement also explicitly highlights additional eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and non-U.S. entities (foreign organizations). This wide eligibility reflects an interest in drawing expertise and participant populations from many settings, which can be important for studying resilience across diverse groups.
From an administrative standpoint, this is a discretionary grant opportunity offered by NIH in the health funding activity category. The original closing date listed is March 26, 2018, and the opportunity was created on December 15, 2017. The award ceiling is listed as $750,000, indicating the upper bound NIH expected to support per award under this announcement (typically interpreted in line with NIH budgeting conventions as total costs unless otherwise specified in the full FOA). The listing shows "ExpectedAwards:" without a number, so the public summary does not specify how many awards NIH planned to make.
In practical terms, competitive applications under this FOA would be expected to show real integration across fields (for example, neurodegeneration expertise paired with advanced statistics, machine learning, network biology, and careful phenotype definition), access to well-characterized participant data and biospecimens, and a credible plan for handling complex molecular datasets. The overall goal is to move toward biologically grounded, predictive understanding of why some high-risk individuals stay cognitively intact, laying a foundation for future strategies that could mimic or enhance those protective processes.Apply for RFA AG 18 029
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2017-12-15.
- Applicants must submit their applications by 2018-03-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $750,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Pacific Coastal Salmon Recovery Fund
Previous opportunity: Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01- Clincal Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 18 029
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 18 029) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required) Apply for PAR 18 432 Funding Number: PAR 18 432 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic Trials of Managing Multimorbidity in Alzheimers Disease (R01 Clinical Trial Required) Apply for RFA AG 18 028 Funding Number: RFA AG 18 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional) Apply for PAR 18 433 Funding Number: PAR 18 433 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional) Apply for PA 18 500 Funding Number: PA 18 500 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional) Apply for RFA AT 18 003 Funding Number: RFA AT 18 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) Apply for PAR 18 513 Funding Number: PAR 18 513 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed) Apply for RFA TW 17 001 Funding Number: RFA TW 17 001 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional) Apply for PA 18 507 Funding Number: PA 18 507 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 025 Funding Number: RFA AG 18 025 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) Apply for PAR 18 522 Funding Number: PAR 18 522 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional) Apply for PA 18 508 Funding Number: PA 18 508 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional) Apply for PAR 18 543 Funding Number: PAR 18 543 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) Apply for PAR 18 534 Funding Number: PAR 18 534 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed) Apply for PAR 18 516 Funding Number: PAR 18 516 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) Apply for PAR 18 521 Funding Number: PAR 18 521 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 525 Funding Number: PA 18 525 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) Apply for PAR 18 523 Funding Number: PAR 18 523 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed) Apply for PAR 18 519 Funding Number: PAR 18 519 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional) Apply for PAR 18 542 Funding Number: PAR 18 542 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional) Apply for PAR 18 528 Funding Number: PAR 18 528 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 18 029", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
